Seattle, WA (February 28, 2020) – Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Accolade intends to list its common stock on the Nasdaq Global Select Market under the ticker symbol ACCD.
Former Health Technology Advisor to the World Bank and Technology Innovator in AI and Commercial Healthcare Solutions to Lead Accolade's Clinical Strategy and Vision
Rx Savings Solutions Partners With Accolade To Provide Pharmacy Transparency Through Leading Personalized Advocacy Solution
Working together, the companies will use people plus technology to drive pharmacy benefit engagement and savings for employers and members
Accolade Expands Partner Ecosystem with New Trusted Supplier Program, Integrating Best-in-class Benefit Solutions for Employers
Ten-step Partner Validation Process Designed to Achieve Highest Quality, Value and Results for Employers, with Personalized Engagement Strategies around Diabetes, Second Opinion, Telemedicine, Women's Health and More
Strategic Investment from Humana Designed to Strengthen and Expand the Integrated Offering from Accolade and Humana
Accolade Expands Health Assistant Center to Seattle, Announces Hundreds of New Clinical and Advocacy Positions Open Around the Country
Former Microsoft Executive Peter Klein to Join Accolade Board
New Accolade Total Care Guides People to the Best Providers and Supports Them at Every Stage of Care to Improve Health Outcomes and Reduce Employer Healthcare Costs
New Healthcare Solution Combines Provider Quality Insights Gained through the Acquisition of MD Insider, Cost Transparency and Personalized Support from Accolade Nurses
Former chairman and CEO of drugstore.com joins prestigious group of healthcare, technology and business executives working to change the healthcare experience in the U.S.
Rajeev Singh, CEO of Accolade, Named Entrepreneur Of The Year 2019 Award Winner in the Pacific Northwest Region
Seattle (June 17, 2019) - Accolade and EY today announced that Rajeev Singh, CEO of Accolade, a personalized advocacy solution for employers and their members, received the Entrepreneur Of The Year® 2019 Award in the Innovator category, Pacific Northwest region. As the world's most prestigious business awards program for entrepreneurs, Entrepreneur Of The Year recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities, while also transforming our world. Singh was selected by an independent panel of judges, and the award was presented at a black-tie gala event in Seattleon June 14.
Accolade and Humana Integrate their Solutions to Optimize the Consumer Experience and Control Healthcare Spend for Self-funded Employers
(Seattle & Louisville, KY) - Mar 15, 2019--Accolade and Humana Inc. (NYSE: HUM) announced today that the two companies will integrate their capabilities to create a differentiated healthcare and benefits experience for consumers. The companies will bring employers and their health plan members the benefit of Humana’s provider networks and innovative medical, dental, pharmacy, Employee Assistance Program (EAP), Work-life Services, and Go365 wellness reward program capabilities together with Accolade’s robust member engagement services and integrated health and benefits partner programs.